Have your own idea? Try our Stock Screener
Pakistani (KSE) Healthcare Sector Analysis
UpdatedJul 24, 2026
DataAggregated Company Financials
Companies15
- 7D-3.5%
- 3M-2.0%
- 1Y-7.3%
- YTD-14.1%
Over the last 7 days, the Healthcare industry has dropped 3.5%, driven by declines in Abbott Laboratories (Pakistan) and GlaxoSmithKline Pakistan of 5.6% and 4.3%, respectively. However, the industry is down 7.3% over the past year. Looking forward, earnings are forecast to grow by 11% annually.
Sector Valuation and Performance
Has the Pakistani Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 25 Jul 2026 | PK₨501.5b | PK₨365.6b | PK₨38.0b | 14.7x | 13.2x | 1.4x |
| Mon, 22 Jun 2026 | PK₨523.8b | PK₨365.6b | PK₨38.0b | 15.4x | 13.8x | 1.4x |
| Wed, 20 May 2026 | PK₨478.6b | PK₨365.6b | PK₨38.0b | 14.1x | 12.6x | 1.3x |
| Fri, 17 Apr 2026 | PK₨529.5b | PK₨359.2b | PK₨36.6b | 14.4x | 14.5x | 1.5x |
| Sun, 15 Mar 2026 | PK₨475.5b | PK₨352.6b | PK₨33.9b | 13.9x | 14x | 1.3x |
| Tue, 10 Feb 2026 | PK₨610.0b | PK₨344.2b | PK₨32.9b | 17.6x | 18.6x | 1.8x |
| Thu, 08 Jan 2026 | PK₨623.2b | PK₨344.2b | PK₨32.9b | 17.4x | 19x | 1.8x |
| Sat, 06 Dec 2025 | PK₨557.1b | PK₨344.3b | PK₨33.1b | 15.6x | 16.9x | 1.6x |
| Mon, 03 Nov 2025 | PK₨573.3b | PK₨344.4b | PK₨33.7b | 16.5x | 17x | 1.7x |
| Wed, 01 Oct 2025 | PK₨606.9b | PK₨332.0b | PK₨32.4b | 20.5x | 18.7x | 1.8x |
| Fri, 29 Aug 2025 | PK₨574.9b | PK₨322.7b | PK₨29.4b | 22.4x | 19.6x | 1.8x |
| Sun, 27 Jul 2025 | PK₨539.3b | PK₨312.5b | PK₨28.6b | 19.7x | 18.9x | 1.7x |
| Tue, 24 Jun 2025 | PK₨483.4b | PK₨312.5b | PK₨28.6b | 17.1x | 16.9x | 1.5x |
| Thu, 22 May 2025 | PK₨501.9b | PK₨312.5b | PK₨28.6b | 17.9x | 17.5x | 1.6x |
| Sat, 19 Apr 2025 | PK₨542.0b | PK₨304.3b | PK₨25.4b | 20.9x | 21.4x | 1.8x |
| Mon, 17 Mar 2025 | PK₨522.2b | PK₨297.7b | PK₨23.0b | 19.9x | 22.7x | 1.8x |
| Wed, 12 Feb 2025 | PK₨541.8b | PK₨287.8b | PK₨20.9b | 23.9x | 25.9x | 1.9x |
| Fri, 10 Jan 2025 | PK₨499.3b | PK₨287.8b | PK₨20.9b | 19.2x | 23.8x | 1.7x |
| Sun, 08 Dec 2024 | PK₨507.6b | PK₨287.7b | PK₨20.8b | 21.8x | 24.4x | 1.8x |
| Tue, 05 Nov 2024 | PK₨384.6b | PK₨289.3b | PK₨21.1b | 15x | 18.2x | 1.3x |
| Thu, 03 Oct 2024 | PK₨299.6b | PK₨281.4b | PK₨14.1b | 12.4x | 21.3x | 1.1x |
| Sat, 31 Aug 2024 | PK₨275.7b | PK₨280.0b | PK₨13.5b | 12.8x | 20.5x | 1x |
| Mon, 29 Jul 2024 | PK₨256.0b | PK₨272.9b | PK₨9.7b | 14.3x | 26.5x | 0.9x |
| Wed, 26 Jun 2024 | PK₨257.1b | PK₨272.9b | PK₨9.7b | 14.6x | 26.6x | 0.9x |
| Fri, 24 May 2024 | PK₨243.1b | PK₨266.0b | PK₨9.0b | 14.6x | 26.9x | 0.9x |
| Sun, 21 Apr 2024 | PK₨203.7b | PK₨257.0b | PK₨8.2b | 19.7x | 24.7x | 0.8x |
| Tue, 19 Mar 2024 | PK₨184.2b | PK₨252.3b | PK₨8.0b | 12.3x | 23x | 0.7x |
| Thu, 15 Feb 2024 | PK₨177.5b | PK₨248.2b | PK₨7.9b | 12.5x | 22.5x | 0.7x |
| Sat, 13 Jan 2024 | PK₨185.4b | PK₨248.2b | PK₨7.9b | 13.5x | 23.5x | 0.7x |
| Mon, 11 Dec 2023 | PK₨199.2b | PK₨246.3b | PK₨7.7b | 15.3x | 25.7x | 0.8x |
| Wed, 08 Nov 2023 | PK₨164.1b | PK₨245.1b | PK₨7.8b | 12.5x | 21.1x | 0.7x |
| Fri, 06 Oct 2023 | PK₨138.2b | PK₨234.3b | PK₨8.2b | 11.3x | 17x | 0.6x |
| Sun, 03 Sep 2023 | PK₨139.3b | PK₨234.1b | PK₨10.1b | 10.3x | 13.8x | 0.6x |
| Tue, 01 Aug 2023 | PK₨155.9b | PK₨230.3b | PK₨10.4b | 12.6x | 15x | 0.7x |
Price to Earnings Ratio
15x
Current Industry PE
- Investors are pessimistic on the Pakistani Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 13.2x which is lower than its 3-year average PE of 20.0x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 54% per year over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare sector?
| PK Market | -3.36% | |
| Healthcare | -3.49% | |
| Life Sciences | 1.41% | |
| Healthcare Services | -2.99% | |
| Pharma | -3.69% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 48.0x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 20.9x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 11% over the next 5 years.
- However this is lower than its past earnings growth rate of 31% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 11% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OTSU Otsuka Pakistan | PK₨415.49 | 3.5% +PK₨169.2m | 55.3% | PE14.4x | |
| HPL Hoechst Pakistan | PK₨4.04k | 0.3% +PK₨130.9m | 30.8% | PE12.8x | |
| GGGL Ghani Global Glass | PK₨8.91 | 0.9% +PK₨19.1m | -7.4% | PE16.6x | |
| MACTER Macter International | PK₨282.71 | 0.02% +PK₨2.7m | -28.0% | PE15.9x |